Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Rough Valuation ——— MM & AP

<< Previous

Bullboard Posts

Next >>

Post by Gorf79on Jul 02, 2022 2:58pm

282 Views

Post# 34797521

Rough Valuation ——— MM & AP

MM/AP

I've seen both your valuation analysis in the past.

I'm a business school grad but not as astute as you at valuing an as yet unleashed entity....I'm a marketing guy.

I know you both have a handle on the PMX valuation, but I'd love to see your Dialco valuations.

I'd conservatively calculate a 40-50% 5 year market share in Clinic for SAMI and a 65-75% share for DIMI over that same timeline.

Based on the current fully diluted count of what? ... 265mil, what is your Dialco stand alone valuation tell you?

Thanks Man,

Gorf

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing